about
Novel endogenous angiogenesis inhibitors and their therapeutic potentialRoles of platelet factor 4 in hematopoiesis and angiogenesisPulmonary hypertension and vascular remodeling in mice exposed to crystalline silicaThe anti-angiogenic peptide anginex disrupts the cell membrane.Chemokines as mediators of tumor angiogenesis and neovascularizationChemokines as mediators of neovascularizationIsoflavones are safe compounds for therapeutical applications - evaluation of in vitro data.Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria.Phosphatase inhibitors with anti-angiogenic effect in vitroThe role of platelets in tumour growth.Gene expression analyses of mouse aortic endothelium in response to atherogenic stimuliExpression of protein kinase CK2 in astroglial cells of normal and neovascularized retinaRole of chemokines in tumor growth.Unaltered Angiogenesis-Regulating Activities of Platelets in Mild Type 2 Diabetes Mellitus despite a Marked Platelet HyperreactivityLow-molecular-weight heparins and angiogenesis.Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey.The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity.Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet Aggregation.NF-kappa B: a new player in angiostatic therapyFibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptideHeparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model.Tumor angiogenesis: insights and innovations.Cattle and chemokines: evidence for species-specific evolution of the bovine chemokine system.The role of CXC chemokines and their receptors in the progression and treatment of tumors.Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype.Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility.Intraplaque neovascularization as a novel therapeutic target in advanced atherosclerosis.Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.Pigment epithelium-derived factor (PEDF): a novel trophoblast-derived factor limiting feto-placental angiogenesis in late pregnancy.Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging.Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice.Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.Altered angiogenesis in low birth weight individuals: a role for anti-angiogenic circulating factors.Cellular and Molecular Changes in MNU-Induced Breast Tumours Injected with PF4 or bFGFThe Role of Angiogenesis in Cancer Treatment.Platelet factor 4 (CXCL4) seals blood clots by altering the structure of fibrin.
P2860
Q26781297-38B734E1-60D8-4E82-BE37-027B0134714EQ28294538-1DC3A316-DE24-443C-8B03-2399006A3807Q28395110-803E4159-9D7C-44BE-B76D-FECAEDB715F0Q30159968-2B4057D8-960E-480F-A26F-A7147DEBA12FQ30427886-06C57EAD-866B-4AAA-8B9F-E8BE378F0B7CQ30438032-3BCFA6AE-47C6-4E0E-ADFF-6685C76D3003Q33480555-E3AB7A05-17A9-40FB-AC94-3640BC0DDD5FQ33573493-57C2D520-B67A-4838-BD20-0BB70B494F2FQ33588814-FA5683C7-0EA6-4316-8215-E7C9CD241411Q33803558-3B1C399A-8831-47A6-A64C-71614E156044Q33927042-ED2B8DAA-A9B6-4747-866B-180B9F23C83CQ35088245-95AC3EB7-4966-4FEB-B6DB-B950BE4BB892Q36120825-50DE5D6A-D339-4957-AFE2-A4555EDA3DC3Q36128546-C926A186-0A52-46BC-BEA0-5098C39FF0C8Q36414904-5CCFAD8C-2BBE-45A9-9E67-5171BBAEC1C0Q36489766-BC342D02-827C-4B28-9D64-15C4B6FE5EAEQ36793120-FD83B322-A452-4B87-812E-EBFBE17C2F5AQ36841086-EAB90E6D-1898-4ADD-BB1E-F9F25D409633Q37088045-7B47490B-78E7-4A9D-B40B-D7C9AD4007F1Q37294970-DC25A192-B673-483B-A1BD-6C28D204B376Q37634740-FE75B418-FD4C-4F3A-BFE0-4BDC9CC1B372Q37743207-C20B75CC-9D25-4D40-9A72-088783B0D084Q37900334-A0EE8BCA-D7B0-41E6-93ED-DB78FD81013AQ38023245-872E75E9-3ABA-4F65-A4C0-ADEA0E424A19Q38674677-09D98B3D-534C-4443-BBC6-C67118AFAB95Q38757723-2C3D7522-2003-4D4E-B067-DD0245448B70Q38826454-6D68873A-4E0A-4D4F-8762-88D2C86809C7Q38974266-1D45F4C4-07C1-41B3-9E98-D896FF20136BQ39698792-444F8478-A237-4C29-8ABB-8A49F2BDD761Q41444120-F63421CE-6E0A-4852-870C-3653D76A1948Q42099455-AE195D7E-6CD2-4EC5-A0B9-A9133D0F9ABFQ45857995-C2BAB1C5-8033-49D7-A052-4B379B5F1C6CQ47233830-5A405F2D-43EE-4BB3-AC98-E0828FC672A4Q47559793-D553064F-98A1-4044-8997-2422A21B98E2Q50932310-8882B182-D7F4-47DF-BFF8-D88F9894AA0DQ53589389-CA41BB72-FAF6-48B4-A200-84F1B6B9D609
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Platelet factor 4: an inhibitor of angiogenesis.
@ast
Platelet factor 4: an inhibitor of angiogenesis.
@en
type
label
Platelet factor 4: an inhibitor of angiogenesis.
@ast
Platelet factor 4: an inhibitor of angiogenesis.
@en
prefLabel
Platelet factor 4: an inhibitor of angiogenesis.
@ast
Platelet factor 4: an inhibitor of angiogenesis.
@en
P356
P1476
Platelet factor 4: an inhibitor of angiogenesis.
@en
P2093
Andreas Bikfalvi
P304
P356
10.1055/S-2004-831051
P577
2004-06-01T00:00:00Z